US Edition7 Articles
7 Articles
According to its own statements, the US biotech company Moderna has won a case before the European Patent Office in a dispute with rivals Pfizer and Biontech over its corona vaccine. The European Patent Office had decided to maintain the validity of Moderna's EP949 patent. It is assumed that the rivals would appeal against this. Pfizer and Biontech did not initially comment. Just one of several patent disputes, this is one of several patent disp…
Moderna, an American pharmaceutical company involved in the research and development of new drugs and vaccines, has won a dispute with the European Patent Office (EPO) with the rival Pfizer/BioNTech consortium over the patent of an mRNA method for the use of its Covid-19 vaccine. However, the verdict of the court is not final. The information was reported by Reuters.
Moderna wins case in patent dispute with Pfizer, BioNTech over COVID shot
(Reuters) -Moderna has won a case at the European Patent Office in its dispute with Pfizer and BioNTech over its COVID-19 vaccine, the company said on Friday. “We are pleased to announce that the European Patent Office decided to maintain the validity of Moderna’s EP949 patent, one of the key patents currently asserted against Pfizer and BioNTech in various European national courts,” Moderna said in an emailed statement. The company said it expe…
FRANKFURT/CAMBRIDGE/NEW YORK. According to its own statements, the US biotech company Moderna has won a case before the European Patent Office in a dispute with rivals Pfizer and Biontech over its corona vaccine.
Coverage Details
Bias Distribution
- 60% of the sources are Center
To view factuality data please Upgrade to Premium
